Discovery of 3-Cyano-N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-5-yObenzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor Related Orphan Receptor C2 Inverse Agonist

被引：25

作者：

Schnute, Mark E. ^{[1
]}

Wennerstal, Mattias ^{[6
]}

Alley, Jennifer ^{[2
]}

Bengtsson, Martin ^{[6
]}

Blinn, James R. ^{[4
]}

Bolten, Charles W. ^{[5
]}

Braden, Timothy ^{[5
]}

Bonn, Tomas ^{[6
]}

Carlsson, Bo ^{[6
]}

Caspers, Nicole ^{[3
]}

Chen, Ming ^{[3
]}

Choi, Chulho ^{[3
]}

Collis, Leon P. ^{[2
]}

Crouse, Kimberly ^{[2
]}

Farnegardh, Mathias ^{[6
]}

Fennell, Kimberly F. ^{[3
]}

Fish, Susan ^{[2
]}

Flick, Andrew C. ^{[3
]}

Goos-Nilsson, Annika ^{[6
]}

Gullberg, Hjalmar ^{[6
]}

Harris, Peter K. ^{[5
]}

Heasley, Steven E. ^{[3
]}

Hegen, Martin ^{[2
]}

Hromockyj, Alexander E. ^{[5
]}

Hu, Xiao ^{[5
]}

Husman, Bolette ^{[6
]}

Janosik, Tomasz ^{[6
]}

Jones, Peter ^{[1
]}

Kaila, Neelu ^{[1
]}

Kallin, Elisabet ^{[6
]}

Kauppi, Bjorn ^{[6
]}

Kiefer, James R. ^{[4
]}

Knafels, John ^{[3
]}

Koehler, Konrad ^{[6
]}

Kruger, Lars ^{[6
]}

Kurumbail, Ravi G. ^{[3
]}

Kyne, Robert E., Jr. ^{[3
]}

Li, Wei ^{[2
]}

Lofstedt, Joakim ^{[6
]}

Long, Scott A. ^{[4
]}

Menard, Carol A. ^{[3
]}

Mente, Scot

Messing, Dean

Meyers, Marvin J. ^{[4
]}

Napierata, Lee ^{[2
]}

Noteberg, Daniel ^{[6
]}

Nuhant, Philippe ^{[3
]}

Pelc, Matthew J. ^{[4
]}

Prinsen, Michael J. ^{[5
]}

Rhonnstad, Patrik ^{[6
]}

机构：

[1] Pfizer Inc, Med Design, Cambridge, MA 02139 USA

[2] Pfizer Inc, Inflammat & Immunol Res, Cambridge, MA 02139 USA

[3] Pfizer Inc, Med Design, Groton, CT 06340 USA

[4] Pfizer Inc, Worldwide Med Chem, St Louis, MO 63017 USA

[5] Pfizer Inc, Inflammat & Immunol Res, St Louis, MO 63017 USA

[6] Karo Pharma AB, S-11148 Stockholm, Sweden

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2018年 / 61卷 / 23期

关键词：

ROR-GAMMA-T; NUCLEAR RECEPTOR; MONOCLONAL-ANTIBODY; DOUBLE-BLIND; SECUKINUMAB; PSORIASIS; IDENTIFICATION; LIGANDS; DIFFERENTIATION; INFLAMMATION;

D O I：

10.1021/acs.jmedchem.8b00392

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The nuclear hormone receptor retinoic acid receptor-related orphan C2 (RORC2, also known as ROR gamma t) is a promising target for the treatment of autoimmune diseases. A small molecule, inverse agonist of the receptor is anticipated to reduce production of IL-17, a key proinflammatory cytokine. Through a high-throughput screening approach, we identified a molecule displaying promising binding affinity for RORC2, inhibition of IL-17 production in Th17 cells, and selectivity against the related RORA and RORB receptor isoforms. Lead optimization to improve the potency and metabolic stability of this hit focused on two key design strategies, namely, iterative optimization driven by increasing lipophilic efficiency and structure-guided conformational restriction to achieve optimal ground state energetics and maximize receptor residence time. This approach successfully identified 3-cyano- N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1 H-pyrrolo[2,3- b]pyridin-5-yl)benzamide as a potent and selective RORC2 inverse agonist, demonstrating good metabolic stability, oral bioavailability, and the ability to reduce IL-17 levels and skin inflammation in a preclinical in vivo animal model upon oral administration.

引用

页码：10415 / 10439

页数：25

共 50 条

[31] Discovery of 6-((3H-imidazo[4,5-b]pyridin-2-yl)methyl)-3-(2,4,6-trifluorobenzoyl)-1H-pyrrolo[2,3-c]pyridin-7(6H)-one (MK2684): A potent inhibitor of MAP/MAPKAP2 (MK2) for the treatment of asthma
Dykstra, Kevin
Chen, Meng-Hsin
Yang, Ginger
Koyama, Hiroo
Miller, Dan
Sahoo, Soumya
Meinke, Peter
O'keefe, Stephen
Gray, Peter
Chiu, Shiow-Ling
Porter, Gene
DeMartino, Julie
Zaller, Denis
Tan, Christopher
Slipetz, Deborah
Corley, Ed
Nelson, Todd
Yu, Hongshi
Farrer, Brian
Madeira, Maria
Karram, Bindhu
Owens, Karen
Mitra, Kaushik
Miller, Glen
Nargund, Ravi
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
[32] MEDI 363-Discovery and SAR of a series of 3-[(6-piperidine-4-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-ones as IGF-1 receptor kinase inhibitors
Liu, Peiying
Velaparthi, Upender
Wittman, Mark D.
Saulnier, Mark G.
Zimmermann, K.
Sang, Xiaopeng
Frennesson, David B.
Lee, Francis Y.
Carboni, Joan
Greer, Ann
Li, Aixin
Attar, Ricardo
Gottardis, Marco
Yang, Zheng
Vyas, Dolatrai M.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
[33] EFFECT OF THE SELECTIVE N-METHYL-D-ASPARTATE RECEPTOR AGONIST 3-(2-CARBOXYPIPERAZIN-4-YL)PROPYL-1-PHOSPHONIC ACID ON [H-3]FLUNITRAZEPAM BINDING
WHITE, HS
BENDER, AS
SWINYARD, EA
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 147 (01) : 149 - 151
[34] Potent platelet-derived growth factor-β receptor (PDGF-βR) inhibitors:: Synthesis and structure-activity relationships of 7-[3-(cyclohexylmethyl)ureido]-3-{1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl}quinoxalin-2(1H)-one derivatives
Aoki, Katsuyuki
Obata, Tatsuhiro
Yamazaki, Yosuke
Mori, Yoshikazu
Hirokawa, Hiroko
Koseki, Jun-ichi
Hattori, Tomohisa
Niitsu, Kazuaki
Takeda, Shuichi
Aburanda, Masaki
Miyamoto, Ken-ichi
CHEMICAL & PHARMACEUTICAL BULLETIN, 2007, 55 (02) : 255 - 267
[35] Novel tricyclic inhibitors of IKK2: Discovery and SAR leading to the identification of 2-methoxy-N-((6-(1-methyl-4-(methylamino)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-7-yl)pyridin-2-yl)methyl)acetamide (BMS-066)
Watterson, Scott H.
Langevine, Charles M.
Van Kirk, Katy
Kempson, James
Guo, Junquing
Spergel, Steven H.
Das, Jagabandhu
Moquin, Robert V.
Dyckman, Alaric J.
Nirschl, David
Gregor, Kurt
Pattoli, Mark A.
Yang, XiaoXia
McIntyre, Kim W.
Yang, Guchen
Galella, Michael A.
Booth-Lute, Hollie
Chen, Laishun
Yang, Zheng
Wang-Iverson, David
McKinnon, Murray
Dodd, John H.
Barrish, Joel C.
Burke, James R.
Pitts, William J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (23) : 7006 - 7012
[36] 5-chloro-N-(4-methoxy-3-piperazin-1-yl-phenyl)-3-methyl-2-benzothiophenesulfonamide (SB-271046):: A potent, selective, and orally bioavailable 5-HT6 receptor antagonist
Bromidge, SM
Brown, AM
Clarke, SE
Dodgson, K
Gager, T
Grassam, HL
Jeffrey, PM
Joiner, GF
King, FD
Middlemiss, DN
Moss, SF
Newman, H
Riley, G
Routledge, C
Wyman, P
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (02) : 202 - 205
[37] Discovery of 2-(1-(3-Chloro-4-cyanophenyl)-1H-pyrazol-3-yl)acetamides as Potent, Selective, and Orally Available Antagonists Targeting the Androgen Receptor
Chen, Changwei
Chai, Xin
Hu, Xueping
Lou, Shengying
Li, Dan
Hou, Tingjun
Cui, Sunliang
JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (19) : 13074 - 13093
[38] NEW HETEROCYCLIC REARRANGEMENT - TRANSFORMATION OF 1-SUBSTITUTED 4-(ALKYLAMINO)-1H-PYRROLO[3,2-C]PYRIDINES INTO 1-SUBSTITUTED 4-(ALKYLAMINO)-1H-PYRROLO[2,3-B]PYRIDINES (5-AZAINDOLES TO 7-AZAINDOLES)
BISAGNI, E
LEGRAVEREND, M
LHOSTE, JM
JOURNAL OF ORGANIC CHEMISTRY, 1982, 47 (08): : 1500 - 1503
[39] 5-(3-Cyclopentyl-2-thioxo-2,3-dihydro-1H-benzimidazol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile:: A novel, highly potent, selective, and orally active non-steroidal progesterone receptor agonist
Zhang, Puwen
Terefenko, Eugene
Kern, Jeffrey
Fensome, Andrew
Trybulski, Eugene
Unwalla, Ray
Wrobel, Jay
Lockhead, Susan
Zhu, Yuan
Cohen, Jeffrey
LaCava, Margaret
Winneker, Richard C.
Zhang, Zhiming
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (20) : 6556 - 6564
[40] Discovery of 3-Chloro-N-{(S)-[3-(1-ethyl-1H-pyrazol-4-yl)phenyl][(2S)-piperidine-2-yl]methyl}-4-(trifluoromethyl)pyridine-2-carboxamide as a Potent Glycine Transporter 1 Inhibitor
Yamamoto, Shuji
Shibata, Tsuyoshi
Abe, Kumi
Oda, Koji
Aoki, Takeshi
Kawakita, Yasunori
Kawamoto, Hiroshi
CHEMICAL & PHARMACEUTICAL BULLETIN, 2016, 64 (09) : 1321 - 1337

← 1 2 3 4 5 →